Table 2 Peri- and post transplant clinical data of the study group
Variables | T1DM SPK (n = 89) | T2 DM SPK (n = 12) | T2DM KTA (n = 26) | p-value |
|---|---|---|---|---|
One-year cumulative combined kidney and pancreas Rejection | ||||
 Yes | 19 (21.3%) | 7 (58.3%) | 4 (15.4%) | n.s. |
 No | 70 (78.7.%) | 5 (41.7%) | 22 (84.6%) |  |
DGF Pancreas | Â | Â | N.A. | n.s. |
 Yes | 4 (4.5%) | 1 (8.3%) |  |  |
 No | 85 (95.5%) | 11 (91.7%) |  |  |
DGF kidney | Â | Â | Â | 0.04 |
 Yes | 13 (14.9%) | 2 (16.7%) | 11 (42.3%) |  |
 No | 74 (85.1%) | 10 (83.3%) | 15 (57.7%) |  |
Infectious Complications | Â | Â | Â | n.s. |
 Yes | 18 (20.2%) | 4 (33.3%) | 10 (38.4%) |  |
 No | 71 (79.8%) | 8 (66.7%) | 16 (61.6%) |  |
Pancreas Complications | ||||
 Graft Thrombosis | ||||
  Yes | 9 (10%) | 1 (9.1%) | N.A. | n.s. |
  No | 79 (90%) | 11 (90.9%) |  |  |
 Abscess/local Infection | ||||
  Yes | 6 (6.7%) | 1 (8.3%) | N.A. | n.s. |
  No | 83 (93.3%) | 11 (91.7%) |  |  |
 Anastomotic leak | ||||
  Yes | 1 (1.1%) | 0 | N.A. | n.s. |
  No | 0 (98.9%) | 0 |  |  |
 Pancreatitis | ||||
  Yes | 11 (12.2%) | 2 (18.2%) | N.A. | n.s. |
  No | 79 (78.2%) | 10 (81.8%) |  |  |
 Bleeding | ||||
  Yes | 8 (9%) | 2 (16.7%) | N.A. | n.s. |
  No | 81 (91%) | 10 (83.3%) |  |  |
C-peptide at discharge, mean (SD), ng/ml | 2.28 (1.8) | 3.19 (1.79) | Â | n.s. |
Creatinine at discharge, mean (SD), ummol/l | 130.5+/−88.1 | 152.1+/−74.7 | 240.3+/−130.1 | < 0.01 |